Literature DB >> 32167489

The convalescent sera option for containing COVID-19.

Arturo Casadevall1, Liise-Anne Pirofski2.   

Abstract

Entities:  

Keywords:  COVID-19

Mesh：

Substances：

Year:  2020        PMID： 32167489      PMCID： PMC7108922          DOI： 10.1172/JCI138003

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  30 in total

1.  Mumps; use of convalescent serum in the treatment and prophylaxis of orchitis.

Authors:  A C RAMBAR
Journal:  Am J Dis Child       Date:  1946-01

2.  Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Authors:  Thomas C Luke; Edward M Kilbane; Jeffrey L Jackson; Stephen L Hoffman
Journal:  Ann Intern Med       Date:  2006-08-29       Impact factor: 25.391

3.  THE USE OF CONVALESCENT HUMAN SERUM IN INFLUENZA PNEUMONIA-A PRELIMINARY REPORT.

Authors:  L W McGuire; W R Redden
Journal:  Am J Public Health (N Y)       Date:  1918-10

4.  A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.

Authors:  Sabue Mulangu; Lori E Dodd; Richard T Davey; Olivier Tshiani Mbaya; Michael Proschan; Daniel Mukadi; Mariano Lusakibanza Manzo; Didier Nzolo; Antoine Tshomba Oloma; Augustin Ibanda; Rosine Ali; Sinaré Coulibaly; Adam C Levine; Rebecca Grais; Janet Diaz; H Clifford Lane; Jean-Jacques Muyembe-Tamfum; Billy Sivahera; Modet Camara; Richard Kojan; Robert Walker; Bonnie Dighero-Kemp; Huyen Cao; Philippe Mukumbayi; Placide Mbala-Kingebeni; Steve Ahuka; Sarah Albert; Tyler Bonnett; Ian Crozier; Michael Duvenhage; Calvin Proffitt; Marc Teitelbaum; Thomas Moench; Jamila Aboulhab; Kevin Barrett; Kelly Cahill; Katherine Cone; Risa Eckes; Lisa Hensley; Betsey Herpin; Elizabeth Higgs; Julie Ledgerwood; Jerome Pierson; Mary Smolskis; Ydrissa Sow; John Tierney; Sumathi Sivapalasingam; Wendy Holman; Nikki Gettinger; David Vallée; Jacqueline Nordwall
Journal:  N Engl J Med       Date:  2019-11-27       Impact factor: 91.245

5.  Transfusion-related acute lung injury in the critically ill: prospective nested case-control study.

Authors:  Ognjen Gajic; Rimki Rana; Jeffrey L Winters; Murat Yilmaz; Jose L Mendez; Otis B Rickman; Megan M O'Byrne; Laura K Evenson; Michael Malinchoc; Steven R DeGoey; Bekele Afessa; Rolf D Hubmayr; S Breanndan Moore
Journal:  Am J Respir Crit Care Med       Date:  2007-07-12       Impact factor: 21.405

6.  Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study.

Authors:  John H Beigel; Jocelyn Voell; Parag Kumar; Kanakatte Raviprakash; Hua Wu; Jin-An Jiao; Eddie Sullivan; Thomas Luke; Richard T Davey
Journal:  Lancet Infect Dis       Date:  2018-01-09       Impact factor: 25.071

7.  Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone.

Authors:  F Sahr; R Ansumana; T A Massaquoi; B R Idriss; F R Sesay; J M Lamin; S Baker; S Nicol; B Conton; W Johnson; O T Abiri; O Kargbo; P Kamara; A Goba; J B W Russell; S M Gevao
Journal:  J Infect       Date:  2016-11-17       Impact factor: 6.072

8.  Use of convalescent plasma therapy in SARS patients in Hong Kong.

Authors:  Y Cheng; R Wong; Y O Y Soo; W S Wong; C K Lee; M H L Ng; P Chan; K C Wong; C B Leung; G Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-01       Impact factor: 3.267

9.  Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

Authors:  Ivan Fn Hung; Kelvin Kw To; Cheuk-Kwong Lee; Kar-Lung Lee; Kenny Chan; Wing-Wah Yan; Raymond Liu; Chi-Leung Watt; Wai-Ming Chan; Kang-Yiu Lai; Chi-Kwan Koo; Tom Buckley; Fu-Loi Chow; Kwan-Keung Wong; Hok-Sum Chan; Chi-Keung Ching; Bone Sf Tang; Candy Cy Lau; Iris Ws Li; Shao-Haei Liu; Kwok-Hung Chan; Che-Kit Lin; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2011-01-19       Impact factor: 9.079

Review 10.  The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

Authors:  John Mair-Jenkins; Maria Saavedra-Campos; J Kenneth Baillie; Paul Cleary; Fu-Meng Khaw; Wei Shen Lim; Sophia Makki; Kevin D Rooney; Jonathan S Nguyen-Van-Tam; Charles R Beck
Journal:  J Infect Dis       Date:  2014-07-16       Impact factor: 5.226
View more
  325 in total

1.  A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.

Authors:  Max R O'Donnell; Beatriz Grinsztejn; Matthew J Cummings; Jessica E Justman; Matthew R Lamb; Christina M Eckhardt; Neena M Philip; Ying Kuen Cheung; Vinay Gupta; Esau João; Jose Henrique Pilotto; Maria Pia Diniz; Sandra Wagner Cardoso; Darryl Abrams; Kartik N Rajagopalan; Sarah E Borden; Allison Wolf; Leon Claude Sidi; Alexandre Vizzoni; Valdilea G Veloso; Zachary C Bitan; Dawn E Scotto; Benjamin J Meyer; Samuel D Jacobson; Alex Kantor; Nischay Mishra; Lokendra V Chauhan; Elizabeth F Stone; Flavia Dei Zotti; Francesca La Carpia; Krystalyn E Hudson; Stephen A Ferrara; Joseph Schwartz; Brie A Stotler; Wen-Hsuan W Lin; Sandeep N Wontakal; Beth Shaz; Thomas Briese; Eldad A Hod; Steven L Spitalnik; Andrew Eisenberger; Walter I Lipkin
Journal:  J Clin Invest       Date:  2021-07-01       Impact factor: 14.808

2.  SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy.

Authors:  Arturo Casadevall; Michael J Joyner; Liise-Anne Pirofski
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

3.  An Urgent Need for "Common Cold Units" to Study COVID-19.

Authors:  Scott B Halstead
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

4.  COVID-19: The Need for Immunoprevention at Industrial Scale.

Authors:  Scott B Halstead
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

5.  B Cells, Viruses, and the SARS-CoV-2/COVID-19 Pandemic of 2020.

Authors:  Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-04-29       Impact factor: 2.257

6.  Promise and challenges in the development of COVID-19 vaccines.

Authors:  Wangxue Chen
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

Review 7.  Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.

Authors:  Esteban Ortiz-Prado; Katherine Simbaña-Rivera; Lenin Gómez-Barreno; Mario Rubio-Neira; Linda P Guaman; Nikolaos C Kyriakidis; Claire Muslin; Ana María Gómez Jaramillo; Carlos Barba-Ostria; Doménica Cevallos-Robalino; Hugo Sanches-SanMiguel; Luis Unigarro; Rasa Zalakeviciute; Naomi Gadian; Andrés López-Cortés
Journal:  Diagn Microbiol Infect Dis       Date:  2020-05-30       Impact factor: 2.803

8.  COVID-19 Special Column: Principles Behind the Technology for Detecting SARS-CoV-2, the Cause of COVID-19.

Authors:  Lauren Ching; Sandra P Chang; Vivek R Nerurkar
Journal:  Hawaii J Health Soc Welf       Date:  2020-05-01

Review 9.  Deployment of convalescent plasma for the prevention and treatment of COVID-19.

Authors:  Evan M Bloch; Shmuel Shoham; Arturo Casadevall; Bruce S Sachais; Beth Shaz; Jeffrey L Winters; Camille van Buskirk; Brenda J Grossman; Michael Joyner; Jeffrey P Henderson; Andrew Pekosz; Bryan Lau; Amy Wesolowski; Louis Katz; Hua Shan; Paul G Auwaerter; David Thomas; David J Sullivan; Nigel Paneth; Eric Gehrie; Steven Spitalnik; Eldad A Hod; Lewis Pollack; Wayne T Nicholson; Liise-Anne Pirofski; Jeffrey A Bailey; Aaron Ar Tobian
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

10.  Emergency seed funding for COVID-19 research: lessons from Johns Hopkins University.

Authors:  Julie Messersmith; Chasmine Stoddart-Osumah; Marc Lennon; Denis Wirtz
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.